aspects of QoL impacted by each procedure. Decisionmaking processes regarding whether patients should opt for IC or NB should take into account patient views about these aspects of their preoperative health status and lifestyle. 10 That is, rather than basing treatment decisions on reports of superior QoL, decisions are best when tailored to individual patient's needs and preoperative lifestyles and values. 9, 11, 12 Unfortunately, there is little information regarding patient views in this context. Studies have suggested patients choosing IC tend to report poorer body image satisfaction and less active lifestyles; whereas, those choosing NB report increased concerns with urinary leakage. 13 One qualitative study 9 identified that procedure and lifestyle factors were secondary to survival considerations, and that most patients adapted to reconstruction. However, beyond this, patients tended to choose IC because of perceived simplicity of this operation, or the fear of urinary incontinence, and extra 'work' for the patient involved in having NB; and chose NB because of perceptions of normality and less restricted activities.
The present research used a quantitative approach to explore further patient lifestyles, concerns and values, associated with choosing either IC or NB. It is hoped that this information will provide medical professionals with a better understanding of the factors important to patients in making their treatment decisions, which will help to ensure that the right guidance is given to patients regarding their decision.
Methods

Participants
Sixty-two participants, who had been treated for advanced bladder cancer (grade pT1 and above), and had chosen either IC or NB procedures, responded to advertisements regarding the study. The advertisements were sent to patients identified by health organisations (boards/trusts), and participants came from multiple sites in the UK. All had their operation not less than one year previously, nor more than five years before. Thirty-eight participants chose IC (14 men, 24 women; mean age 62 years), and 24 participants chose NB (18 men, six women; mean age 52 years). No form of payment was offered for participation.
Materials
The European Organization for Research and Treatment quality of life questionnaire (EORTC QLQ-30) 14 is a patient-completed 30-item questionnaire that assesses QoL outcomes relevant to cancer patients. Each item asks about a specific symptom or aspect of the patient's life, and is answered on a four-point scale ('not at all', 'a little', quite a bit', 'very much'). There are a number of scales produced, and this study used the functioning scales: physical functioning; role functioning; emotional functioning; cognitive functioning; social functioning. Each scale produces a score between 0 (low) and 100 (high). The scale also gives a global health status (0-100).
The life values inventory (LVI) 15 is a patient-completed 42-item questionnaire. Each item asks about whether a specific value guides behaviour on a five-point scale ('almost never' to 'almost always'). It measures patientheld values across a number of domains: achievement; belonging; concern for the environment; concern for others; creativity; financial prosperity; health and activity; humility; independence; loyalty to family or group; privacy; responsibility; scientific understanding; and spirituality. Each scale produces a score between 3 (low) and 15 (high).
The bladder reconstruction satisfaction questionnaire (BRSQ) was a new questionnaire developed for this study, and is a patient-completed, 11-item tool concerned with patient views on the aspects of the reconstruction that were most important to them. These questions were constructed with input from consultant urologists involved in the treatment and care of bladder cancer patients. One item asks about levels of satisfaction with bladder reconstruction on a five-point scale ('very satisfied' to 'very dissatisfied'). Another item asks about the aspects of participants' lives prior to surgery that were important to them (body image; ability to return to normality; ease of passing urine; incontinence; sexual function; removing the cancer quickly; urine infections; maintenance of bladder; physical activity; and severity of surgery), rated on a seven-point scale ('very unimportant' to 'very important').
Results
All participants indicated that they had chosen their bladder reconstruction procedure. Table 1 presents the gender breakdown of these procedure choices. These data show that, while there was a relatively even split across the procedures for men, most women had chosen IC, χ 2 (1)=8.57, P<0.001, ϕ=0.372.
In terms of satisfaction with their bladder replacement (assessed by a question in the BRSQ), 28 participants indicated that they were 'very satisfied', 27 that they were 'satisfied', four 'neither satisfied or dissatisfied', no participants indicated that they were 'dissatisfied' or 'very dissatisfied', and three participants did not answer this question.
The remaining analyses were conducted only on those participants who were 'very satisfied' or 'satisfied' (N=55). The mean age of those participants who had chosen IC was 62.25 (+8.82) years, and the mean age of those choosing NB was 51.64 (+11.57), t(53)=3.86, P<0.001, d=1.01. Table 2 shows these satisfaction data for each of the procedures, and reveals that more participants were 'very satisfied' with IC than with NB, χ 2 (1)=34.29, P<0.001, ϕ=0.790.
In terms of QoL outcomes, as assessed by the EORTC QLQ-30, the participants with IC had a mean global health status of 59.83+1.91, and those with NB had a mean global health status of 66+9.50, t(53)=1.17, P=0.245, d=0.30. This global health status score was not associated with satisfaction with the procedure measured by the BRSQ ('very satisfied', scored as 1; or 'satisfied', scored as 0), r b =−0.127, P>0.30.
The mean scores for the functioning scales of the EORTC QLQ-30 are shown in Figure 1 . Inspection of these data reveals little difference between the two types of bladder replacement in terms of role, t<1, d=0.02, or social, t<1, d=0.10, functioning. There were greater scores for NB in terms of: physical, t(53)=3.20, P<0.001, d=1.25; emotional, t(53)=3.37, P<0.001, d=0.90; and cognitive, t(53)=4.08, P<0.001, d=0.52, functioning. A logistic regression using these factors as predictors, and 'very satisfied' (1) and 'satisfied' (0) from the BRSQ as the outcome, revealed a significant predictive model, -2LL=31.93, χ 2 (5)=42.93, P<0.001, but only physical functioning (β=10.51, P<0.05) was an independent predictor of satisfaction with reconstruction. Figure 2 shows the mean scores for the aspects of the participants' lives that they rated as important to them prior to surgery, according to the BRSQ. Inspection of these data shows that returning to normality, and removal of the cancer, were the most important aspects of the participants' lives prior to the surgery, irrespective of the type of procedure chosen. However, some aspects of life were rated as differentially important between those who opted for IC and NB. In particular, those opting for IC rated maintenance, t(53)=3.84, P<0.001, d=1.60, and severity of surgery, t(53)=5.72, P<0.001, d=2.90, as more important. In contrast, those opting for NB rated the ability to return to normality as more important than those opting for IC, t(53)=4.27, P<0.001, d=0.90. All other comparisons between these groups of participants were not significant, all P>0. 10 . A logistic regression using these factors as predictors, and IC (0) and NB (1) as the outcome, revealed a significant predictive model, -2LL=87.93, χ 2 (5)=59.58, P<0.001, with 'maintenance' (β=−11.38, P<0.001), and 'severity of surgery' (β=−19.11, P<0.001), predicting IC choice, and 'normality' predicting NB choice (β=13.22, P<0.001). Table 3 shows the group means for each of the 13 life values measured by the LVI. These data show that there were some significant differences between the values held by participants who chose IC and those who chose NB. The IC group had higher values in terms of the environment, humility and loyalty; while those choosing NB had higher values in creativity, independence and science. These differences might be summarised as implying values focusing on others favour IC choice; and values focusing on the person (themself) and science, favour NB choice.
Discussion
The findings from the present study provide insight into the factors involved in patients' decision-making processes, and should be viewed as part of a fundamental shift in research from typical HR-QoL studies regarding urinary diversion to a more patient-centred approach. It is among only a few pieces of research to focus on the specific lifestyles, values, views/perceptions, concerns and opinions of patients regarding their choice of urinary diversion, rather than focusing purely on how their choice has subsequently affected their overall QoL. 13 Prior to consideration of the implications of these findings, the retrospective nature of the study should be noted, and there is always the chance of post hoc justification in patient responses. Nevertheless, the results show strong similarity to those that emerged from a qualitative study on this topic. 9 In the current study, women tended to have an IC, and men tended to have a NB; with older participants having IC and younger participants having NB. The majority of participants indicated that they were satisfied with their operation, 5, 8, 9 with a suggestion of greater satisfaction with IC. The difference between this finding, and that previously reported in the qualitative study, 9 in which NB was favoured, is almost certainly produced by the different methods of asking the question in the two studies. The EORTC QLQ-30 scale suggested that any differences in satisfaction between the procedures, in the current study, might be related to physical functioning, which will be highly dependent on participant perceptions of what they desired in this regard. The participants indicated that, although the impact on their lives and their pre-existing values were considerations, these concerns paled relative to that of survival, which is consistent with previous studies. 9 Beyond this key 'survival' issue, the main reasons why participants chose IC was the perception that it offered a quicker, less surgically involved, and safer means to recovery after cancer treatment. 9 These participants also expressed more concerns relating to the degree of work needed to maintain NB, relative to IC. These participants also tended to have what might be termed 'outwardly directed' values, especially concerning others, their relationships with others, and the environment.
A key reason for choosing NB was that participants felt that it was more natural, and allowed a return to perceived normality, relative to IC. 9, 13 The present findings provide evidence consistent with the notion that patients choosing NB have a more active lifestyle. 13 These participants also tended to be concerned with what might be termed more 'inwardly directed' values (e.g. creativity, independence), than those participants who favoured IC. Previous studies have indicated that those choosing NB identify body image as an important factor, when making their decision. 9, 13 Interestingly, the type of bladder reconstruction -partially 'external' for IC and 'internal' for NB -on the whole, match the general values orientation of participants who chose each of these procedures -'outwardly directed' for IC and 'inwardly directed' for NB.
Although the degree of consistency with the few existing studies is encouraging, these suggestions should be treated with caution until they can be extended further, using a wider and larger sample of individuals. The current patients were volunteers, and this will have introduced a selection bias, which needs to be acknowledged, but is difficult to overcome in any study that seeks informed consent. Nevertheless, it is possible that the observations, above, regarding the patient characteristics associated with the choices, may have resulted from such selection bias. In the current sample, very few participants were not satisfied with their procedure, and the results might be different with a wider range of opinion in terms of outcome. The limited size of the sample also precluded any more sophisticated analyses of these data; for example, determining whether different values were associated with reconstruction choice for men and women. The current data were collected with only a limited range of measurement tools, and it may be that different results would be obtained with a different battery of tools. In addition, the use of psychological scales may illustrate whether some personality factors, alluded to above, could be useful predictors of reconstruction choice. It should be noted that the questionnaires were completed post-surgery, so it cannot be concluded, definitively, that these measures predict reconstruction choice. There may have been some degree of post hoc justification, and/or differences in the pre or postoperative counselling, that might have impacted outcomes, and a prospective study is needed to reach that particular conclusion. Once further studies have been conducted to generate a larger, more diverse, sample of patients, the findings could be combined to develop further, and test, a joint patient/consultant decision-aid tool to identify which type of urinary reconstruction may be best suited to the lifestyles, values, and concerns of patients.
In summary, it might be concluded that being older, being a woman, wanting to minimise the risks and difficulties of the surgical procedure, wanting to minimise extra work following the reconstruction, and valuing living your life with regard to others, favours IC. In contrast, being younger, being a man, valuing the way you lived your life before the operation, wanting to do the things that you want to do, and valuing science and technology, favours NB. emerged during this work. Finally, a grateful thank you to Tenovus Cancer Care for providing the funding for this research, in the form of an iGrant, and to Jess Hall, from Tenovus, for her ongoing support and help during the research programme.
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